The crossing of chronic total occlusions (CTOs) is the key step for an endovascular treatment. The Ocelot system is a novel device that combines a steerable drilling tip with optical coherence tomography (OCT) technology. It provides intraluminal imaging to help the crossing of CTOs in the femoropopliteal segment. Aim of the study was to determine early and midterm results after recanalization with this device.
Methods and Results:
During a period of 16 months, 84 CTOs were treated using the Ocelot system and prospectively registered. The primary end points were technical success and the primary and secondary patency of the lesion. Risk factors associated with early and midterm results were also analyzed. In all, 58 (69.0%) lesions were treated for intermittent claudication, 26 (31.0%) for critical limb ischemia, 34 (40.5%) were classified as Trans-Atlantic Inter-Society Consensus II D lesions, and 22 (26.2%) showed severe calcifications. The technical success rate was 72.6%. During 36 months of follow-up (mean 25.9), there were 10 reinterventions. The primary and secondary patency at 36 months were 54.2% and 68.1%, respectively.
Conclusions:
In our experience, the Ocelot system would appear to be a safe and effective tool for increasing the applicability of endovascular techniques. However, the midterm results did not show drastic improvement.
ShammasNW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3(2):229–234.
2.
MalyarNFürstenbergTWellmannJ. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J. 2013;34(34):2706–2714.
3.
BisdasTBorowskiMTorselloG; First-Line Treatments in Patients With Critical Limb Ischemia (CRITISCH) Collaborators. Current practice of first-line treatment strategies in patients with critical limb ischemia. J Vasc Surg. 2015;62(4):965–973.e3.
4.
BoliaABrennanJBellPR. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol. 1989;40(3):325.
5.
BoliaAMilesKABrennanJ. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990;13(6):357–363.
DavisBTPToreyJ. Options for Chronic Total Occlusions. Endovasc Today. 2013;5:87–91.
8.
PigottJPRajaMLDavisT. A multicenter experience evaluating chronic total occlusion crossing with the Wildcat catheter (the CONNECT study). J Vasc Surg. 2012;56(6):1615–1621.
PratiFRegarEMintzGS. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31(4):401–415.
11.
GonzaloNGonzaloNEscanedJ. Morphometric assessment of coronary stenosis relevance with optical coherence tomography: a comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol. 2012;59(12):1080–1089.
12.
GambichlerTMoussaGSandMSandDAltmeyerPHoffmannK. Applications of optical coherence tomography in dermatology. J Dermatol Sci. 2005;40(2):85–94.
13.
SelmonMRSchwindtAGCawichIM. Final results of the chronic total occlusion crossing with the Ocelot system II (CONNECT II) study. J Endovasc Ther. 2013;20(6):770–781.
14.
NorgrenLHiattWRDormandyJA. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1–S75.
15.
SchwindtAReimersBScheinertD. Crossing chronic total occlusions with the Ocelot system: the initial European experience. EuroIntervention. 2013;9(7):854–862.
16.
ScheinertDPeetersPBosiersM. Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease. Catheter Cardiovasc Interv. 2007;70(7):1034–1039.
17.
StonerMCCalligaroKDChaerRA. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64(1):e1–e21.
18.
LiangGZZhangFX. Novel devices and specialized techniques in recanalization of peripheral artery chronic total occlusions (CTOs)—a literature review. Int J Cardiol. 2013;165(3):423–429.
19.
CharalambousNSchäferPJTrentmannJ. Percutaneous intraluminal recanalization of long, chronic superficial femoral and popliteal occlusions using the Frontrunner XP CTO device: a single-center experience. Cardiovasc Intervent Radiol. 2010;33(1):25–33.
20.
StaniloaeCSModyKPYadavSS. Endoluminal treatment of peripheral chronic total occlusions using the Crosser® recanalization catheter. J Invasive Cardiol. 2011;23(9):359–362.
21.
BanerjeeSSarodeKDasT. Endovascular treatment of infrainguinal chronic total occlusions using the TruePath device: features, handling, and 6-month outcomes. J Endovasc Ther. 2014;21(2):281–288.
22.
KumeTOkuraHKawamotoT. Assessment of the coronary calcification by optical coherence tomography. EuroIntervention. 2011;6(6):768–772.
23.
HongSJKoYGKimJSHongMKJangYChoiD. Midterm outcomes of subintimal angioplasty supported by primary proximal stenting for chronic total occlusion of the superficial femoral artery. J Endovasc Ther. 2013;20:782–791.
24.
MwipatayiBPHockingsAHofmannMGarbowskiMSieunarineK. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. J Vasc Surg. 2008;47(2):461–469.
IidaOSogaYHiranoK. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther. 2011;18(6):753–761.
27.
SogaYTakaharaMIidaO. Relationship between primary patency and lesion length following bare nitinol stent placement for femoropopliteal disease. J Endovasc Ther. 2015;22(6):862–867. doi:10.1177/1526602815610118.
28.
SchillingerMSabetiSLoeweC. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879–1888.
29.
SchillingerMSabetiSDickP. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115(21):2745–2749.
30.
StavroulakisKBisdasTTorselloGStachmannASchwindtA. Combined directional atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease. J Endovasc Ther. 2015;22(6);847–852. doi:10.1177/1526602815608194.
31.
CioppaAStabileEPopusoiG. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med. 2012;13(4):219–223.
32.
GandiniRDel GiudiceCMerollaSMorosettiDPampanaESimonettiG. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther. 2013;20(6):805–814.
33.
SixtSCarpio CancinoOGTreszlA. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg. 2013;58(3):682–686.
34.
ZellerT. 12-month DEFINITIVE AR results. Paper presented at Vascular InterVentional Advances (VIVA), Las Vegas, NV, November 4–7, 2014.
35.
SchwindtAGBennettJGCrowderWH. Lower extremity revascularization using optical coherence tomography-guided directional atherectomy: final results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for use in the peripheral vasculature (VISION) study. J Endovasc Ther. 2017;24(3):355–366.
36.
McKinseyJFZellerTRocha-SinghKJ. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7(8):923–933.
37.
TepeGZellerTAlbrechtT. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–699.
38.
SchillingerMExnerMMlekuschW. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology. 2002;224(2):529–535.
